Speaker illustration

Doctor Ikuko Anan

Jikei University School of Medicine (Tokyo), Tokyo (Japan)

Long-term benefit of enzyme replacement therapy on cardiac manifestation in Japanese Fabry disease

Event: ESC CONGRESS 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy in Fabry disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk